vs
Side-by-side financial comparison of N2OFF, Inc. (NITO) and SenesTech, Inc. (SNES). Click either name above to swap in a different company.
SenesTech, Inc. is the larger business by last-quarter revenue ($421.0K vs $2.0K, roughly 210.5× N2OFF, Inc.). N2OFF, Inc. runs the higher net margin — 21450.0% vs -428.5%, a 21878.5% gap on every dollar of revenue. On growth, SenesTech, Inc. posted the faster year-over-year revenue change (-16.0% vs -77.8%). Over the past eight quarters, SenesTech, Inc.'s revenue compounded faster (0.7% CAGR vs -86.2%).
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
NITO vs SNES — Head-to-Head
Income Statement — Q3 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $2.0K | $421.0K |
| Net Profit | $429.0K | $-1.8M |
| Gross Margin | — | 55.3% |
| Operating Margin | -66300.0% | -446.8% |
| Net Margin | 21450.0% | -428.5% |
| Revenue YoY | -77.8% | -16.0% |
| Net Profit YoY | 118.9% | -43.7% |
| EPS (diluted) | $0.97 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $421.0K | ||
| Q3 25 | $2.0K | $690.0K | ||
| Q2 25 | $0 | $625.0K | ||
| Q1 25 | $66.0K | $485.0K | ||
| Q4 24 | $140.0K | $501.0K | ||
| Q3 24 | $9.0K | $482.0K | ||
| Q2 24 | $17.0K | $459.0K | ||
| Q1 24 | $44.0K | $415.0K |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $429.0K | $-1.3M | ||
| Q2 25 | $-4.5M | $-1.6M | ||
| Q1 25 | $-1.2M | $-1.7M | ||
| Q4 24 | $-1.4M | $-1.3M | ||
| Q3 24 | $-2.3M | $-1.5M | ||
| Q2 24 | $-787.0K | $-1.6M | ||
| Q1 24 | $-769.0K | $-1.8M |
| Q4 25 | — | 55.3% | ||
| Q3 25 | — | 62.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | 78.8% | 64.5% | ||
| Q4 24 | 61.4% | 60.9% | ||
| Q3 24 | -755.6% | 65.4% | ||
| Q2 24 | 64.7% | 54.2% | ||
| Q1 24 | 36.4% | 32.5% |
| Q4 25 | — | -446.8% | ||
| Q3 25 | -66300.0% | -195.2% | ||
| Q2 25 | — | -258.2% | ||
| Q1 25 | -937.9% | -342.9% | ||
| Q4 24 | -72.1% | -250.9% | ||
| Q3 24 | -15955.6% | -321.0% | ||
| Q2 24 | -4982.4% | -349.0% | ||
| Q1 24 | -2043.2% | -444.1% |
| Q4 25 | — | -428.5% | ||
| Q3 25 | 21450.0% | -188.1% | ||
| Q2 25 | — | -258.6% | ||
| Q1 25 | -1807.6% | -343.3% | ||
| Q4 24 | -980.7% | -250.5% | ||
| Q3 24 | -25155.6% | -313.9% | ||
| Q2 24 | -4629.4% | -345.1% | ||
| Q1 24 | -1747.7% | -441.4% |
| Q4 25 | — | $0.48 | ||
| Q3 25 | $0.97 | $-0.28 | ||
| Q2 25 | $-0.18 | $-0.87 | ||
| Q1 25 | $-0.39 | $-1.28 | ||
| Q4 24 | $-26.86 | $-0.15 | ||
| Q3 24 | $-0.39 | $-2.07 | ||
| Q2 24 | $-0.23 | $-3.08 | ||
| Q1 24 | $-0.26 | $-3.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.3M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.9M | $9.6M |
| Total Assets | $11.0M | $12.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.6M | ||
| Q3 25 | $6.3M | $10.2M | ||
| Q2 25 | $3.4M | $6.1M | ||
| Q1 25 | $3.0M | $1.7M | ||
| Q4 24 | $2.2M | $1.3M | ||
| Q3 24 | $2.7M | $2.5M | ||
| Q2 24 | $4.5M | $2.0M | ||
| Q1 24 | $3.5M | $3.6M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | $8.9M | $11.3M | ||
| Q2 25 | $5.8M | $7.0M | ||
| Q1 25 | $3.9M | $2.9M | ||
| Q4 24 | $4.7M | $2.5M | ||
| Q3 24 | $5.4M | $3.7M | ||
| Q2 24 | $6.0M | $3.1M | ||
| Q1 24 | $5.8M | $4.6M |
| Q4 25 | — | $12.8M | ||
| Q3 25 | $11.0M | $14.6M | ||
| Q2 25 | $7.8M | $10.4M | ||
| Q1 25 | $7.4M | $3.6M | ||
| Q4 24 | $5.5M | $3.3M | ||
| Q3 24 | $5.8M | $4.4M | ||
| Q2 24 | $7.5M | $4.0M | ||
| Q1 24 | $6.3M | $5.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-974.0K | $-1.7M |
| Free Cash FlowOCF − Capex | — | $-1.7M |
| FCF MarginFCF / Revenue | — | -398.3% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | -2.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $-974.0K | $-1.4M | ||
| Q2 25 | $-528.0K | $-1.1M | ||
| Q1 25 | $-809.0K | $-1.6M | ||
| Q4 24 | $-492.0K | $-1.2M | ||
| Q3 24 | $-891.0K | $-1.4M | ||
| Q2 24 | $-1.0M | $-1.6M | ||
| Q1 24 | $-1.0M | $-1.8M |
| Q4 25 | — | $-1.7M | ||
| Q3 25 | — | $-1.4M | ||
| Q2 25 | — | $-1.2M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | — | -398.3% | ||
| Q3 25 | — | -205.9% | ||
| Q2 25 | — | -191.5% | ||
| Q1 25 | — | -328.5% | ||
| Q4 24 | — | -246.1% | ||
| Q3 24 | — | -296.1% | ||
| Q2 24 | — | -354.2% | ||
| Q1 24 | — | -441.2% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 6.1% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 5.8% | ||
| Q2 24 | — | 8.5% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | -2.27× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
